NexPoint Life Sciences DST
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$105M
Investors
236
Min Invest
$100,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
NexPoint Life Sciences DST is a Delaware entity that first filed a Form D on December 28, 2021 and most recently amended it on June 6, 2022 in the Other Real Estate industry group. The offering claims Rule 506(b) and covers equity. NexPoint Life Sciences DST reported $104,959,651 sold from 236 investors of a $107,550,012 total offering as of the Form D filed June 6, 2022. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $100,000. The Form D names Emerson Equity LLC (CRD 130032), associated with None; Maxwell Financial Group, Inc. (CRD 167863), associated with None; TCFG Wealth Management, LLC (CRD 164153), associated with None; Great Point Capital LLC (CRD 114203), associated with None and 20 others as recipients of sales compensation soliciting in CA, CO, FL, KY, NV, TX. The issuer's address of record is 300 Crescent Court, Suite 700, Dallas, TX 75201.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
lapsed
Fund family Part of the NexPoint Life Sciences DST family: 3 vehicles across 2 generations · full family and the filing behind each link in the terminal
Investor
- The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
NexPoint Real Estate Advisors IV, L.P.
Executive Officer · Dallas, TX
Sponsor of the Issuer
Matthew Goetz
Executive Officer · Dallas, TX
Authorized Signatory of the Issuer
Matt McGraner
Executive Officer · Dallas, TX
Authorized Signatory of the Issuer
NREA Casper, LLC
Executive Officer · Dallas, TX
Manager and Signatory Trustee of the Issuer
NREA Casper Investment Co, LLC
Executive Officer · Dallas, TX
Contributor of the Issuer
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
Emerson Equity LLCCRD 130032 on BrokerCheck
Associated broker-dealer: None · San Mateo, CA · Soliciting in CA, CO, FL, KY, NV, TX
Maxwell Financial Group, Inc.CRD 167863 on BrokerCheck
Associated broker-dealer: None · Manhattan Beach, CA · Soliciting in CA
TCFG Wealth Management, LLCCRD 164153 on BrokerCheck
Associated broker-dealer: None · Laguna Niguel, CA · Soliciting in CT, FL
Great Point Capital LLCCRD 114203 on BrokerCheck
Associated broker-dealer: None · Chicago, IL · Soliciting in CO, FL, IL, MA, ME, NJ, NY
Centaurus Financial, Inc.CRD 30833 on BrokerCheck
Associated broker-dealer: None · Anaheim, CA · Soliciting in CA, FL, NV, NY, TN, UT
Concorde Investment Services LLCCRD 151604 on BrokerCheck
Associated broker-dealer: None · Livonia, MI · Soliciting in AL, CA, FL, GA, HI, IA, ID, IN, LA, MA, NJ, NV, NY, OH, OR, TN, TX, UT, WA
Stax CapitalCRD 300607 on BrokerCheck
Associated broker-dealer: None · San Diego, CA · Soliciting in CA, CO, HI, KS, NV, OR, WA
Thornhill Securities, Inc.CRD 22333 on BrokerCheck
Associated broker-dealer: None · Austin, TX · Soliciting in CA, CO, FL, KS, LA, TN, TX, WA
Growth Capital Services, Inc.CRD 124658 on BrokerCheck
Associated broker-dealer: None · Claymont, DE · Soliciting in CA, FL
Lightpath Capital, Inc.CRD 34617 on BrokerCheck
Associated broker-dealer: None · Southlake, TX · Soliciting in AZ, CA, NC
McDermott Investment Services, LLCCRD 154926 on BrokerCheck
Associated broker-dealer: None · Bethlehem, PA · Soliciting in NJ
Innovation Partners LLCCRD 146344 on BrokerCheck
Associated broker-dealer: None · Charlotte, NC · Soliciting in CA, NE
Capulent LLCCRD 155155 on BrokerCheck
Associated broker-dealer: None · Phoenix, AZ · Soliciting in CA, MN, NC, NM
Metropolitan Capital Investment Banc, Inc.CRD 148820 on BrokerCheck
Associated broker-dealer: None · Chicago, IL · Soliciting in CO, IL, NY, UT
American Trust Investment Services, Inc.CRD 3001 on BrokerCheck
Associated broker-dealer: None · Whiting, IN · Soliciting in CA, FL, NH, NV, OH
Patrick Capital Markets, LLCCRD 16518 on BrokerCheck
Associated broker-dealer: None · St. Louis, MO · Soliciting in CA, DC, MA, VA
Wilson-Davis & Co., Inc.CRD 3777 on BrokerCheck
Associated broker-dealer: None · Salt Lake City, UT · Soliciting in UT
Network 1 Financial Securities Inc.CRD 13577 on BrokerCheck
Associated broker-dealer: None · Red Bank, NJ · Soliciting in CO, KY
Kalos Capital, Inc.CRD 44337 on BrokerCheck
Associated broker-dealer: None · Alpharetta, GA · Soliciting in FL, GA
Whitehall-Parker Securities, Inc.CRD 10608 on BrokerCheck
Associated broker-dealer: None · San Rafael, CA · Soliciting in CA, MA, OR, TX
FNEX Capital, LLCCRD 166316 on BrokerCheck
Associated broker-dealer: None · Indianapolis, IN · Soliciting in CA, MD, NC, RI
Huntwicke Securities, LLCCRD 146993 on BrokerCheck
Associated broker-dealer: None · Topsfield, MA · Soliciting in MA
Dempsey Lord Smith, LLCCRD 141238 on BrokerCheck
Associated broker-dealer: None · Rome, GA · Soliciting in FL
Stonecrest Capital Markets, Inc.CRD 39616 on BrokerCheck
Associated broker-dealer: None · Austin, TX · Soliciting in LA
Questions About NexPoint Life Sciences DST
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is NexPoint Life Sciences DST?
NexPoint Life Sciences DST is a Delaware entity that filed a Form D with the SEC on June 6, 2022 in the Other Real Estate industry group. The filing claims Rule 506(b) for an offering of equity.
Is NexPoint Life Sciences DST legit?
AltStreet does not rate legitimacy; it reports the public record. NexPoint Life Sciences DST filed a Form D with the SEC on June 6, 2022 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $104,959,651 sold to 236 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is NexPoint Life Sciences DST registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that NexPoint Life Sciences DST claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has NexPoint Life Sciences DST raised?
NexPoint Life Sciences DST reported $104,959,651 sold from 236 investors of a $107,550,012 total offering as of the Form D filed June 6, 2022.
Who can invest in NexPoint Life Sciences DST?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $100,000.
What is the minimum investment in NexPoint Life Sciences DST?
The Form D lists $100,000 as the minimum investment accepted from any outside investor as of June 6, 2022. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling NexPoint Life Sciences DST and how are they paid?
The Form D names Emerson Equity LLC (CRD 130032), associated with None; Maxwell Financial Group, Inc. (CRD 167863), associated with None; TCFG Wealth Management, LLC (CRD 164153), associated with None; Great Point Capital LLC (CRD 114203), associated with None and 20 others as recipients of sales compensation soliciting in CA, CO, FL, KY, NV, TX.
Who is behind NexPoint Life Sciences DST?
The Form D lists 5 related persons: NexPoint Real Estate Advisors IV, L.P., executive officer (Sponsor of the Issuer); Matthew Goetz, executive officer (Authorized Signatory of the Issuer); Matt McGraner, executive officer (Authorized Signatory of the Issuer); NREA Casper, LLC, executive officer (Manager and Signatory Trustee of the Issuer); NREA Casper Investment Co, LLC, executive officer (Contributor of the Issuer). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is NexPoint Life Sciences DST located?
The issuer's address on its SEC filings is 300 Crescent Court, Suite 700, Dallas, TX 75201. Its phone number of record is (833) 697-6246. It is organized under the laws of Delaware.
How long is the NexPoint Life Sciences DST offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 13 amendments are on record for this CIK.
What is NexPoint Life Sciences DST's revenue?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.